References
Diaz JC, Vallejo S, Canas CA (2012) Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab. Rheumatol Int 32(10):3315–3317
Song IH, Heldmann F, Rudwaleit M, Listing J, Appel H, Braun J et al (2010) Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum 62(5):1290–1297
Kiltz U, Heldmann F, Baraliakos X, Braun J (2012) Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives? Curr Opin Rheumatol 24(3):252–260
Heldmann F, Dybowski F, Saracbasi-Zender E, Fendler C, Braun J (2010) Update on biologic therapy in the management of axial spondyloarthritis. Curr Rheumatol Rep 12(5):325–331
Costa MF, Said NR, Zimmermann B (2008) Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum 37(6):381–387
Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A (2005) Drug-induced lupus erythematosus. Autoimmunity 38(7):507–518
Williams EL, Gadola S, Edwards CJ (2009) Anti-TNF-induced lupus. Rheumatology (Oxford) 48(7):716–720
De Bandt M, Sibilia J, Le Loet X, Prouzeau S, Fautrel B, Marcelli C et al (2005) Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 7(3):R545–R551
Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L et al (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86(4):242–251
Lin J, Ziring D, Desai S, Kim S, Wong M, Korin Y et al (2008) TNF alpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 126(1):13–30
Subramanian S, Yajnik V, Sands BE, Cullen G, Korzenik JR (2011) Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. Inflamm Bowel Dis 17(1):99–104
van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, Derksen RH, van Roon JA (2006) Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level. Rheumatology (Oxford) 45(10):1317–1319
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akgül, Ö., Kılıç, G., Kılıç, E. et al. A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept. Rheumatol Int 34, 443–444 (2014). https://doi.org/10.1007/s00296-012-2617-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2617-8